뒤로
Stella Diagnostics Inc(SLDX) 가격
SLDX 주가 차트
SLDX 수입
Stella Diagnostics Inc
$0.01
0%
$0
종가: Feb 06, 16:00:00 GMT-5
$0.01
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
아직 데이터 없음Earnings FAQ
SLDX의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Stella Diagnostics Inc SLDX의 지난 분기 매출 실적은 어땠나요?
Stella Diagnostics Inc의 매출 추정치는 얼마인가요?
Stella Diagnostics Inc의 수익 품질 점수는 얼마인가요?
Stella Diagnostics Inc는 언제 수익을 보고하나요?
Stella Diagnostics Inc의 예상 수익은 얼마인가요?
Stella Diagnostics Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0154
시가
$0.014
일일 범위
$0.014 - $0.0154
52주 범위
$0.0111 - $0.0585
거래량
20
평균 거래량
543
EPS(TTM)
--
배당수익률
--
시가총액
$1.5M
SLDX란 무엇인가요?
Stella Diagnostics, Inc. operates as a molecular diagnostics-based organization, which focuses on improving patient management strategies. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2003-07-29. The Company’s proprietary technology is based on rigorous research by domain experts and practicing physicians and can notify providers if common diseases of the esophagus like GERD and Barrett’s esophagus express proteins associated with normal or carcinogenic processes. Its panel of biomarkers and targeted proteomics method, the company can better inform gastroenterologists, surgical oncologists and pathologists which patients are high risk for disease progression into precancer or cancer. The predictive panel will be offered as a Laboratory Developed Test (LDT) in a CAP/CLIA Certified moderate complexity laboratory. Its subsidiaries include SLDX, Inc. and Galaxy Pharmaceuticals LLC.